151 related articles for article (PubMed ID: 28196776)
1. EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature.
Berti A; Felicetti M; Peccatori S; Bortolotti R; Guella A; Vivaldi P; Morelli L; Barabareschi M; Paolazzi G
Joint Bone Spine; 2018 Jan; 85(1):35-40. PubMed ID: 28196776
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.
Rizzi R; Curci P; Delia M; Rinaldi E; Chiefa A; Specchia G; Liso V
Med Oncol; 2009; 26(1):1-9. PubMed ID: 18461290
[TBL] [Abstract][Full Text] [Related]
6. Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases.
Kojima M; Itoh H; Hirabayashi K; Igarashi S; Tamaki Y; Murayama K; Ogura H; Saitoh R; Kashiwabara K; Takimoto J; Masawa N; Nakamura S
Pathol Res Pract; 2006; 202(9):679-85. PubMed ID: 16859835
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
8. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: a study of 49 cases.
Kojima M; Motoori T; Itoh H; Shimizu K; Iijima M; Tamaki Y; Murayama K; Ohno Y; Yoshida K; Masawa N; Nakamura S
Int J Surg Pathol; 2005 Jul; 13(3):273-8. PubMed ID: 16086083
[TBL] [Abstract][Full Text] [Related]
9. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.
Kameda H; Okuyama A; Tamaru J; Itoyama S; Iizuka A; Takeuchi T
Clin Rheumatol; 2007 Sep; 26(9):1585-9. PubMed ID: 17200802
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.
Abruzzo LV; Rosales CM; Medeiros LJ; Vega F; Luthra R; Manning JT; Keating MJ; Jones D
Am J Surg Pathol; 2002 May; 26(5):630-6. PubMed ID: 11979093
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis.
Tokuhira M; Watanabe R; Nemoto T; Sagawa M; Tomikawa T; Tamaru J; Itoyama S; Nagasawa H; Amano K; Kameda H; Takeuchi T; Mori S; Kizaki M
Leuk Lymphoma; 2012 Apr; 53(4):616-23. PubMed ID: 21933041
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
19. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
Satou A; Banno S; Hanamura I; Takahashi E; Takahara T; Nobata H; Katsuno T; Takami A; Ito Y; Ueda R; Nakamura S; Tsuzuki T
Pathol Int; 2019 Jan; 69(1):21-28. PubMed ID: 30615240
[TBL] [Abstract][Full Text] [Related]
20. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
